Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  Nrf2 activator RTA 408
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
RTA 408 Capsules in Patients With Melanoma - REVEAL
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: RTA 408-C-1401, NCI-2015-00144, NCT02259231
RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVER
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 75
Trial IDs: RTA 408-C-1303, NCI-2014-00379, NCT02029729
Start Over